Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.27182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Marina P Menegolla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Newborn Section, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Anti-Bacterial Agents, Infant, Very Low Birth Weight, Infant, Premature. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: None.
Themen: Neonatologie
Abstract (Originalsprache)
Background
Bronchopulmonary dysplasia (BPD) remains a significant challenge in neonatal care. Prenatal inflammation and neonatal sepsis contribute to the multifactorial nature of BPD. A potential association between empirical antibiotic therapy and BPD risk has been proposed due to microbiota dysbiosis in very low birth weight premature infants.
Methods
A single centered retrospective cohort study of preterm infants (24–32 weeks gestation) from 2014 to 2021. The study compared groups that received empirical antibiotics in the first days of life and those that did not receive any antibiotic in the first days of life. The primary outcomes studied were BPD, death, and the combined outcome of BPD/death. Statistical analysis employed t ‐tests, Mann‐Whitney U, Chi‐square, and logistic regression.
Results
Of 454 preterm infants, 61.5% received antibiotics. This group had lower gestational age, birth weight, and Apgar scores. Antibiotic use was associated with higher incidence of BPD (35.5% vs. 10.3%), death (21.5% vs. 8.6%), and combined outcomes (54.5% vs. 18.3%). In multivariate analysis, antibiotic use independently associated with BPD (OR 2.58, p < 0.001) and combined outcome BPD/death (OR 2.06, p < 0.02). Antenatal corticosteroids provided protection against BPD, but not mortality.
Conclusion
This study suggests an association between early empirical antibiotic use and BPD in preterm infants, emphasizing the need for judicious antibiotic practices in neonatal care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Newborn Section, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
ORCID-Profile: Renato S Procianoy
Förderung
- None
Zitieren
APA
Menegolla, M. P., Silveira, R. C., Görgen, A. R. H., Gandolfi, F. E., & Procianoy, R. S. (2024). Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27182
Vancouver
Menegolla MP, Silveira RC, Görgen ARH, Gandolfi FE, Procianoy RS. Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27182
BibTeX
@article{Menegolla2024,
author = {Menegolla, Marina P and Silveira, Rita C and Görgen, Antônio R H and Gandolfi, Fernanda E and Procianoy, Renato S},
title = {Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.27182}
}
EUVIMED